Diwakar Davar

40PUBLICATIONS
180CO-AUTHORS
Tumour immunologyChemotherapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 20, 2026
Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies.

|May 15, 2026
Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma.

|May 13, 2026
Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy.

|Jan 29, 2026
Advancing ICOS agonism in solid tumors: lessons from INDUCE-1.

Parham Habibzadeh, Diwakar Davar

|Jul 31, 2025
Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption.

Kristin M Morder, Madison Nguyen, Drew N Wilfahrt

|Jul 09, 2025
Therapeutic potential of targeting LAG-3 in cancer.

Diwakar Davar, Ana Carrizosa Anderson, Ivan Diaz-Padilla

Pageof 7

Frequent Collaborators

8 joint publications

Jason John Luke

5 joint publications

John M Kirkwood

5 joint publications

Yana G Najjar

3 joint publications

Zeynep Eroglu